Total Clarity Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25
Closed -$1K 513
2022
Q2
$1K Buy
+25
New +$1.64K ﹤0.01% 971
2022
Q1
Sell
-25
Closed -$2K 479
2021
Q4
$2K Sell
25
-400
-94% -$29K ﹤0.01% 909
2021
Q3
$33K Buy
+425
New +$34.1K 0.02% 462
2021
Q2
Sell
-425
Closed -$26K 385
2021
Q1
$26K Buy
+425
New +$26.9K 0.01% 428

Other funds holding GMED

Total Clarity Wealth Management's GMED Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Globus Medical (GMED) in Q3 2022, closing a stake of 25 shares — an estimated $1K sold.

Total Clarity Wealth Management first reported a position in GMED in Q1 2021 and held it in 4 quarters. The position peaked at $33K in Q3 2021. 370 funds tracked by Wall St. Rank hold GMED as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Globus Medical position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 25 Globus Medical shares in Q3 2022, an estimated $1K.
  • Total Clarity Wealth Management first reported a position in Globus Medical in Q1 2021 and held it in 4 quarters.
  • Total Clarity Wealth Management's Globus Medical position peaked at $33K in Q3 2021.
  • 370 funds tracked by Wall St. Rank held Globus Medical as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.